JPH11507016A - 貯蔵安定性ヘモグロビン溶液 - Google Patents

貯蔵安定性ヘモグロビン溶液

Info

Publication number
JPH11507016A
JPH11507016A JP8533458A JP53345896A JPH11507016A JP H11507016 A JPH11507016 A JP H11507016A JP 8533458 A JP8533458 A JP 8533458A JP 53345896 A JP53345896 A JP 53345896A JP H11507016 A JPH11507016 A JP H11507016A
Authority
JP
Japan
Prior art keywords
hemoglobin
composition
solution
storage
oxygen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP8533458A
Other languages
English (en)
Japanese (ja)
Inventor
エイ． カーウィン，ブルース
エル． ルッカー，ダグラス
Original Assignee
ソマトジェン，インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ソマトジェン，インコーポレイテッド filed Critical ソマトジェン，インコーポレイテッド
Publication of JPH11507016A publication Critical patent/JPH11507016A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/805—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
JP8533458A 1995-05-02 1996-05-01 貯蔵安定性ヘモグロビン溶液 Pending JPH11507016A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/433,896 1995-05-02
US08/433,896 US5929031A (en) 1995-05-02 1995-05-02 Storage stable hemoglobin solutions
PCT/US1996/006080 WO1996034889A1 (en) 1995-05-02 1996-05-01 Storage stable hemoglobin solutions

Publications (1)

Publication Number Publication Date
JPH11507016A true JPH11507016A (ja) 1999-06-22

Family

ID=23721974

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8533458A Pending JPH11507016A (ja) 1995-05-02 1996-05-01 貯蔵安定性ヘモグロビン溶液

Country Status (7)

Country Link
US (1) US5929031A (de)
EP (1) EP0826004B1 (de)
JP (1) JPH11507016A (de)
AT (1) ATE203546T1 (de)
CA (1) CA2216382A1 (de)
DE (1) DE69614105T2 (de)
WO (1) WO1996034889A1 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6964798B2 (en) 1993-11-16 2005-11-15 Baxter International Inc. Multi-layered polymer based thin film structure for medical grade products
US6242417B1 (en) * 1994-03-08 2001-06-05 Somatogen, Inc. Stabilized compositions containing hemoglobin
US6271351B1 (en) 1995-03-23 2001-08-07 Biopure Corporation Method for preserving a hemoglobin blood substitute
US6610832B1 (en) 1995-03-23 2003-08-26 Biopure Corporation Preserving a hemoglobin blood substitute with a transparent overwrap
US6288027B1 (en) 1995-03-23 2001-09-11 Biopure Corporation Preserving a hemoglobin blood substitute with a transparent overwrap
US6018035A (en) * 1997-07-21 2000-01-25 Baxter International Inc. Reagents for isotropic size enhancement of a peptide, protein, nucleotide or other substrate
US5981710A (en) * 1997-07-21 1999-11-09 Baxter International, Inc. Therapeutic hemoglobin composition having isotropically increased size
US6204254B1 (en) 1997-09-12 2001-03-20 Baxter International, Inc. Biocompatible surfaces and a method for their preparation
KR100674690B1 (ko) * 1999-07-01 2007-01-25 시스멕스 가부시키가이샤 헤모글로빈 안정화수단
JP3466516B2 (ja) 1999-09-07 2003-11-10 科学技術振興事業団 安定保存可能な酸素輸液剤
US6894150B1 (en) 1999-10-01 2005-05-17 Ross Walden Tye Non-pyrogenic, endotoxin-free, stroma-free tetrameric hemoglobin
US7449339B2 (en) * 1999-11-23 2008-11-11 Nir Diagnostics Inc. Spectroscopic method and apparatus for total hemoglobin measurement
US6949384B2 (en) * 2001-12-21 2005-09-27 Spectromedical Inc. Method for monitoring degradation of Hb-based blood substitutes
FR2809624B1 (fr) * 2000-05-31 2002-08-02 Centre Nat Rech Scient Utilisation comme substitut sanguin d'une hemoglobine extracellulaire de poids moleculaire eleve
US6974447B2 (en) * 2001-04-17 2005-12-13 Baxter International Inc. High gas barrier receptacle and closure assembly
CA2444590C (en) * 2001-04-18 2009-12-01 Robert L. Mcginnis Stabilized hemoglobin solutions
CA2474134C (en) * 2002-01-15 2015-11-17 Board Of Regents, The University Of Texas System Methods and compositions to reduce scattering of light during therapeutic and diagnostic imaging procedures
CA2476589C (en) * 2002-02-27 2014-02-25 Pharmain, Ltd. Compositions for delivery of therapeutics and other materials, and methods of making and using the same
US7635463B2 (en) * 2002-02-27 2009-12-22 Pharmain Corporation Compositions for delivery of therapeutics and other materials
US20050276823A1 (en) * 2002-07-12 2005-12-15 Cini John K Methods and compositions for preventing oxidative degradation of proteins
US7223604B1 (en) * 2002-09-27 2007-05-29 Science & Technology Corporation @ Unm Methods and kits for the detection of erythrocytes
JP2006516994A (ja) * 2003-01-29 2006-07-13 ノースフィールド ラボラトリーズ、インコーポレイテッド テトラマーの量を低下させた重合ヘモグロビン溶液及び調製するための方法
WO2005112977A2 (en) * 2004-04-23 2005-12-01 Pharmain, Ltd. Compositions for treatment with glucagon-like peptide, and methods of making and using the same
BRPI0510291A (pt) 2004-04-27 2007-10-30 Baxter Int sistema de reator com tanque agitado
JP2006164312A (ja) * 2004-12-02 2006-06-22 Hitachi Ltd 半導体装置およびそれを用いた磁気記録再生装置
CA2600927C (en) 2005-03-07 2017-04-18 Sangart, Inc. Compositions and methods for delivering carbon monoxide (co) and nitric oxide (no) to tissue using heme proteins as carriers
WO2007087570A2 (en) * 2006-01-24 2007-08-02 Northfield Laboratories, Inc. Polymerized hemoglobin media and its use in isolation and transplantation of islet cells
US20090004159A1 (en) * 2006-01-24 2009-01-01 The Board Of Trustees Of The University Of Illinoi Polymerized Hemoglobin Media and Its Use in Isolation and Transplantation of Islet Cells
US7504377B2 (en) * 2006-10-23 2009-03-17 Ikor, Inc. Nitric oxide-blocked cross-linked tetrameric hemoglobin
US7494974B2 (en) * 2006-10-24 2009-02-24 Ikor, Inc. Carboxymethylated cross-linked tetrameric hemoglobin
JP2008195656A (ja) * 2007-02-14 2008-08-28 Nipro Corp 人工酸素運搬体製剤
US8609815B2 (en) 2010-09-02 2013-12-17 Sangart, Inc. Methods for preparing stable deoxygenated PEG-hemoglobin conjugate solutions comprising an antioxidant
WO2012094671A2 (en) * 2011-01-07 2012-07-12 Somerset Group Enterprises, Inc. Modular extracorporeal systems and methods for treating blood-borne diseases
WO2013106443A1 (en) 2012-01-09 2013-07-18 Somerset Group Enterprises, Inc. Modular extracorporeal systems and methods for treating blood-borne diseases
US9763889B2 (en) * 2015-06-29 2017-09-19 Billion King International Ltd. Oral delivery system for hemoglobin based oxygen carriers
US10052290B2 (en) * 2016-02-04 2018-08-21 Billion King International Ltd. Enteric-coated hemoglobin multiparticulate for oral delivery of hemoglobin based oxygen carriers
WO2021204948A1 (en) * 2020-04-09 2021-10-14 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and compositions to determine the quality of red blood cell units

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3144705C2 (de) * 1981-11-11 1983-12-08 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Verfahren zur Herstellung eines lagerstabilen, vernetzten Hämoglobinpräparates mit hoher Sauerstoff-Transportkapazität, sowie das nach diesem Verfahren hergestellte Hämoglobinpräparat
US4727027A (en) * 1983-05-02 1988-02-23 Diamond Scientific Co. Photochemical decontamination treatment of whole blood or blood components
US4861867A (en) * 1988-02-03 1989-08-29 Baxter International, Inc. Purified hemoglobin solutions and method for making same
US5234903A (en) * 1989-11-22 1993-08-10 Enzon, Inc. Chemically modified hemoglobin as an effective, stable non-immunogenic red blood cell substitute
US5352773A (en) * 1990-08-06 1994-10-04 Baxter International Inc. Stable hemoglobin based composition and method to store same
ATE130761T1 (de) * 1990-08-06 1995-12-15 Baxter Int Stabiles mittel auf hämoglobinbasis und verfahren zu dessen einlagerung.
AU9067791A (en) * 1990-11-20 1992-06-11 Enzon, Inc. Method of enhancing long-term storage stability of hemoglobin products
SE9301581D0 (sv) * 1993-05-07 1993-05-07 Kabi Pharmacia Ab Protein formulation

Also Published As

Publication number Publication date
CA2216382A1 (en) 1996-11-07
DE69614105D1 (de) 2001-08-30
DE69614105T2 (de) 2002-03-21
US5929031A (en) 1999-07-27
WO1996034889A1 (en) 1996-11-07
AU708264B2 (en) 1999-07-29
EP0826004A1 (de) 1998-03-04
AU5852096A (en) 1996-11-21
EP0826004B1 (de) 2001-07-25
ATE203546T1 (de) 2001-08-15

Similar Documents

Publication Publication Date Title
JPH11507016A (ja) 貯蔵安定性ヘモグロビン溶液
CA2473662C (en) Methods and compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
Abraham et al. Allosteric modifiers of hemoglobin: 2-[4-[[(3, 5-disubstituted anilino) carbonyl] methyl] phenoxy]-2-methylpropionic acid derivatives that lower the oxygen affinity of hemoglobin in red cell suspensions, in whole blood, and in vivo in rats
US7989414B2 (en) Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
CA2600927C (en) Compositions and methods for delivering carbon monoxide (co) and nitric oxide (no) to tissue using heme proteins as carriers
DE69823211T2 (de) No-modifizierte Hämoglobine und Verwendung dafür
Frietsch et al. Artificial oxygen carriers
CA2578232C (en) Methods to enhance hemodynamic stability using oxygen carrying compositions
WO1999018979A1 (en) Storage-stable hemoglobin composition
AU708264C (en) Storage stable hemoglobin solutions
Papassotiriou et al. Modulating the oxygen affinity of human fetal haemoglobin with synthetic allosteric modulators
FI106362B (fi) Menetelmä verenkorvikkeena käytettäväksi soveltuvan koostumuksen valmistamiseksi
Dinkelmann et al. Artificial Oxygen Carriers–a Critical Analysis
Gu Engineering the Biophysical and Biochemical Properties of Polymerized Hemoglobin as a Red Blood Cell Substitute via Various Strategies
Waschke et al. Oxygen-carrying blood substitutes
Holley Synthetic blood products: science fiction or coming to an ICU near you?
REPERFUSION POLYHEMOGLOBIN-SUPEROXIDE DISMUTASE-CATALASE BLOOD SUBSTITUTE FOR ISCHEMIA
Tobias et al. 11 Recombinant haemoglobin and other blood substitutes
EP1894573A2 (de) Verfahren und Zusammensetzungen für den Sauerstofftransport mit hoher Sauerstoffaffinität
US20130219829A1 (en) Method for the preparation of a heat stable oxygen carrier-containing pharmaceutical composition and the use thereof